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COVID-19 mortalities in England and Wales and the Peltzman offsetting effect
Sam Williams, Alasdair Crookes1, Karli Glass2 and Anthony J. Glass34
ABSTRACT
There are two approaches to measuring COVID-19 deaths – ‘COVID associated deaths’ and ‘excess 
deaths’. An excess deaths framework is preferable, as there is measurement error in COVID 
associated deaths, due to issues relating to imperfect information about deaths that are directly 
attributable to COVID-19. The standard measure of excess deaths (comparison of deaths to a 5-year 
average) is subject to an omitted variables problem, as it attributes the entirety of the variation in 
mortality to COVID-19. We propose a method to estimate a refined measure of COVID-19 excess 
deaths in England and Wales that addresses the omitted impact of the first blanket lockdown. 
Using the counterfactual, we obtain a first stage estimate of excess deaths. In the second stage, this 
is decomposed into estimates of a refined measure of COVID-19 excess deaths and the excess 
mortality impact of lockdown. Our results suggest: (i) a refined estimate of mean weekly COVID-19 
excess deaths that is 63% of standard excess deaths; and (ii) a positive net excess mortality impact 
of the lockdown. We make a case that (ii) is due to the Peltzman offsetting effect, i.e. the intended 









There is uncertainty regarding the number of 
deaths that are due to COVID-19 worldwide. This 
is due to known limitations with the two (direct 
and indirect) main measurement approaches.
In England and Wales there are two direct 
metrics.5 Public Health England (PHE) report 
deaths within 28 days of a positive test; and the 
Office of National Statistics (ONS) reports deaths 
where COVID is mentioned on the death certifi-
cate. The main drawbacks of these direct metrics 
are that (i) there are accepted limitations in the 
extent to which they establish mortality causality6; 
and (ii) because the precise application of direct 
methods varies across countries, they are less suited 
to comparative analysis.
The primary indirect metric is ‘excess deaths’. 
This compares total weekly all-cause mortality to 
a 5-year average (in England and Wales the ONS 
reports on this basis).7 The excess deaths metric is 
more comparable (over time and across countries); 
and there is somewhat of a consensus regarding its 
advantages over direct metrics.8 However, it has 
two drawbacks: (i) due to the very high concentra-
tion of COVID-19 deaths in the elderly (Table 1) it 
seems likely that some of these deaths would have 
occurred in any case, and have thus been somewhat 
‘brought-forward’ by the pandemic, rather than 
being truly excess; and (ii) it does not specifically 
relate to COVID-19 deaths, due to the approach 
omitting factors other than COVID-19 that might 
cause total mortalities to vary. The first issue (mor-
tality displacement) cannot be addressed until 
more time has passed. In this paper we therefore 
focus on, and propose a solution to, the omitted 
variables problem relating to England and Wales, 
using statistical techniques.9
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6This limitation is more applicable to the PHE data. However, due to the high rates of comorbidity in relation to COVID-19 deaths, it is also a relevant issue vis-à- 
vis the ONS data.
7As described further by the ONS (2020a).
8For example, the Health Foundation (2020) has stated that: ‘excess deaths is a better measure than COVID-19 deaths of the pandemic’s total mortality [because 
it] does not depend on how COVID-19 deaths are recorded.’ In addition, excess deaths has been advocated by Professor Chris Whitty, the Chief Medical Officer 
for the UK.
9Such methods are commonly used when measuring influenza mortality. For example, Simonsen et al. (1997) apply this approach to identify cyclical deaths 
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A range of variables may cause total mortalities 
to vary, relative to historical averages. Other than 
COVID-19 itself, policies in the form of non- 
pharmaceutical interventions (NPIs) are likely to 
be important factors in explaining mortality varia-
tion during the pandemic. These must therefore be 
parameterized for any refined measure of excess 
deaths to be robust. Accordingly, we test a range 
of plausible variables, including modelling the 
impact of the first lockdown in England and 
Wales (23 March 2020–13 May 2020).10
We adopt a two-stage time series approach.11 In 
line with the 5-year excess deaths framework, in the 
first stage we estimate Poisson models for all-cause 
mortalities for the 5 years that precede the COVID- 
19 period (week ending 23 January 2015 – week 
ending 24 January 2020).12 We then use each fitted 
model to predict out-of-sample counterfactual 
mortalities over the COVID-19 period, which 
runs through to the end of our study time- 
horizon: week ending 28 August 2020. The weekly 
differences between observed all-cause deaths and 
the predicted counterfactual are the first stage 
weekly estimates of excess deaths.13 The first stage 
estimates, however, omit the impact of other vari-
ables; notably, the first national lockdown. 
Accordingly, second stage regressions are then 
used to yield estimates that distinguish between 
the refined measure of COVID-19 excess deaths 
(above) and the excess mortality impact of the 
lockdown. There is, of course, a time-lag between 
infection (i.e. what the lockdown could have 
directly affected) and death (the outcome being 
measured), which we account for in the second 
stage regressions.14
Three main findings from our second stage 
results are as follows. First, under our preferred 
baseline model (which assumes a 4-week lag 
between infection and death) we find that (i) 
COVID-19 excess deaths amount to 63% of the 
standard 5-year average excess deaths; and (ii) in 
net terms, the lockdown increased all-cause mor-
talities (associated with an incremental 2,601 excess 
mortalities per week). Our results are sensitive to 
the time-lag between infection and death; so 
a range of lags are analysed. The evidence in the 
literature is most consistent with a 3 to 4-week lag; 
and a 4-week lag (as applied in our preferred base-
line model) is well supported. Second, although it 
has been widely reported that COVID-19 deaths 
are concentrated in the elderly, we find that such 
deaths have been concentrated in the very elderly 
(75–84 and 85+). Third, we do find that lockdown 
reduced mortality in net terms in some individual 
weeks.
We consider the net mortality increasing effect 
of the first national lockdown may reflect the fact 
that any intended mortality decreasing impact on 
COVID-19 deaths was comparatively smaller than, 
and thus more than offset by, the wider (unin-
tended) mortality increasing impacts. The unin-
tended mortality consequences are consistent with 
people choosing not to access healthcare for non- 
COVID-19 illnesses. We therefore posit that we 
have uncovered an important new case of the well- 
known Peltzman (1975) offsetting effect, which 
proposes that people adjust their behaviour to 
changes in the perceived level of risk (of which 
there are a number of well-known examples, relat-
ing to safety/health policies).
Table 1. Deaths involving COVID-19 in England and Wales: as of 
week ending 28 August 2020.
Age 
group
Number of COVID-19 
deaths













10May 13th was when the most strict lockdown measures were lifted.
11Since England and Wales imposed a national lockdown, quasi-natural experimental approaches are not possible, as the relevant counterfactual cannot be 
observed.
12The week ending 24 January 2020 represents our assumed final week of the ‘pre-pandemic’ period, based on the first known cases occurring on January 30th; 
see BBC (2020).
13This first stage approach is standard and has been widely applied. For example, it was used to estimate excess deaths due to COVID-19 in the U.S., 48 states 
(excluding North Carolina and Connecticut), the District of Columbia and New York City (Weinberger et al. 2020).
14We discuss the evidence on the length of this time-lag in subsection 2.3.
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The plausibility of our finding is supported by 
existing evidence regarding both the (limited) effi-
cacy of the lockdown in achieving its primary aim, 
and the potential for spillover harms. In light of the 
evidence, and the well-established possibility of 
a Peltzman offsetting effect, our finding that the 
first lockdown in England and Wales had a net 
mortality increasing impact should not come as 
a great surprise (although individual policies 
should be evaluated case-by-case).
The remainder of this paper is structured as 
follows. Section 2 summarizes explanatory vari-
ables that affect mortality. Section 3 presents the 
general form of our simple two-stage modelling 
framework. Section 4 describes the data and 
empirical model specifications. In section 5, we 
set out our models and discuss the results. 
Section 6 provides concluding remarks.
Variables that may impact all-cause mortality
Brief overview of the determinants of mortality in 
the literature
Public health, virology, epidemiology and econom-
ics studies point to a number of variables that may 
impact all-cause mortality; as follows:
● Environmental/seasonal patterns. Data shows 
higher mortality in the winter/poor weather; 
and lower mortality in the summer/better 
weather; see Nogueira et al. (2009). 
Temperature can impact mortality, but the 
relationship may be non-linear (mortality 
falls with increases in temperature, but then 
rises as temperatures become very hot). See 
Cech et al. (1979); Huynen et al. (2001). Air 
pollution is positively associated with mortal-
ity; Willers et al. (2016).
● Demographics. Mortality rates increase with 
the proportion of elderly people; Chaix et al. 
(2006).
● Socioeconomic factors. Poverty/income is cited 
as a contributory factor to mortality. The 
empirical evidence appears mixed; Rodgers 
(1979); Cutler, Deaton, and Lleras-Muney 
(2006).
● Population density. Studies have shown 
a positive association between population den-
sity and mortality. This is relevant in the con-
text of virus mortality, as transmission is 
increased where populations are more densely 
located; Meijer et al. (2012).
● Healthcare expenditure, resources and public 
health. Mortality may fall with investment in 
healthcare and/or where healthcare resources 
are increased. In relation to public health, 
obesity, smoking, etc. may cause mortality to 
vary; Cutler, Deaton, and Lleras-Muney 
(2006).
The existing evidence is thus consistent with con-
sidering variables within the above categories.
The role of UK policy in explaining COVID-19 
mortality
Government COVID-19 policy (and within our 
estimation period, the first lockdown) also likely 
impacted mortality. This policy impact must 
therefore be incorporated, to avoid the omitted 
variables problem we aim to address.15 There 
are two broad types of potential lockdown pol-
icy impacts.
First, the direct (intended) impact would typi-
cally be to spread out COVID-19 mortalities. The 
rationale for the first blanket lockdown was framed 
around the concept of mitigation (slowing, but not 
reducing in totality, epidemic spread and related 
deaths). The purpose of this would be to lower peak 
healthcare demand, to protect the National Health 
Service (NHS). Lowering the infection (and thus 
mortality) peak could also reduce mortalities in 
totality, relative to the counterfactual, if said policy 
prevented the NHS being overwhelmed. Second, 
the indirect (unintended) consequences of policy 
responses could be increasing non-COVID-19 
mortality. This would be the case if the policy 
response interrupted healthcare provision and/or 
affected people’s behaviour vis-à-vis broader 
healthcare. We address the evidence regarding 
both impacts subsequently. At this juncture, we 
merely note that the null hypothesis regarding the 
15The omission of a lockdown policy variable would result in the risk that the policy impact is misattributed elsewhere within the second stage model; most 
obviously, to COVID-19 itself.
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net overall mortality effect of a blanket lockdown is 
ambiguous.
Evidence on the time lag between infections, 
symptoms and deaths
Given the need to account for the lockdown in our 
modelling, one must do so in a way that reflects the 
fact that said policy (if effective) directly impacts 
COVID-19 infections, not deaths. Thus, impacts on 
COVID-19 deaths need to take into account the 
‘lag’ from infection to death. The evidence on time 
lags remains uncertain. However, the World 
Health Organization (2020) estimated the mean 
incubation period (infection to symptomatic) at 
5–6 days, with a maximum of 14 days (consistent 
with UK Government quarantine advice). Lauer 
et al. (2020) also suggest a 5-day incubation.
Verity et al. (2020) calculate the average lag 
between symptom and outcome (death or recov-
ery). The study was based on case level data for 
patients that died from COVID-19 in Hubei, 
China. They found the mean duration from symp-
tom to death was 17.8 days.16 The World Health 
Organization (2020) estimated symptom to death 
being between 2 and 8 weeks. Hawryluk et al. 
(2020), using more recent data from Brazil, esti-
mated a shorter lag from symptom to death of 
15.2 days.
Summarizing the above, the Verity et al. study 
implies a total time lag between infection and mor-
tality of 23 days (5 days to symptomatic; plus 
18 days to death). However, the WHO figures 
imply a longer overall period of 40 days (5 days to 
symptomatic; plus the mid-point of their 2 to 
8 week range above – 35 days). The more recent 
Hawryluk et al. analysis implies a total period of 
20 days. Combined, our review of the evidence 
therefore suggests the average total elapsed time 
from infection to death likely lies between >3 and 
<6 weeks. Equally weighting the evidence, mean 
elapsed time from infection to death is 4 weeks.17
Although, on balance, we take the evidence to 
point to a 4-week lag between infection and death, 
we recognize the uncertainty around this estimate. 
We therefore consider the sensitivity of our results 
to lags of 2, 3 and 5 weeks.
III. General form of the two-stage modelling 
framework
First stage modelling
The estimation period for the first stage time series 
models is the pre-COVID period (week ending 
23 January 2015–week ending 24 January 2020), 
where for this sample the time periods are indexed 
t∈1, . . ., T. In the first stage, for each all-cause 
deaths variable (in totality, by age category, etc.) 
that we analyse, we assume that the observed num-
ber of deaths in period t, yt, is Poisson 
distributed.18 
ytePoisson μ mð Þ½ �;
where the density of yt is determined by the 
conditional mean μ mð Þ;E ytjmð Þ and m is 
explained by a set of determinants. The general 
form of our first stage models is as follows. 
μ mð Þ ¼ exp β0xtð Þ þ εt (1) 
where xt is a vector of observations in period t for 
the independent variables that explain m, β0
denotes a vector of parameters to be estimated 
comprising parameters pertaining to xt and the 
intercept parameter, and εt denotes the idiosyn-
cratic disturbance.
Estimating each of the first stage models involves 
specifying the Poisson family of distributions using 
the log link function as this is canonical to this 
family. As a result, the estimates of the 
xtparameters are coefficients (not marginal effects), 
16With a 95% confidence interval of 16.9 to 19.2 days.
17This is also the time period from a positive COVID-19 test to mortality that the ONS use as one of the measures of associated deaths. The more recent 
empirical studies are arguably supportive of a 3-week lag. Hence, one might say the evidence is most consistent with a 3–4 week lag ‘in the round’.
18We estimate each of the first stage models using maximum likelihood estimation of a generalized linear model (GLM) Poisson regression. For each model we 
use robust standard errors which we estimate using the Huber / White / Sandwich linearized estimator of the variance. Silva and Tenreyro (2006) demonstrate 
that an important advantage of the Poisson regression with robust standard errors is that it does not assume that the conditional mean of the dependent 
variable is equal to its conditional variance. Moreover, turning to whether the general form of the first stage models should instead be a negative binomial 
model, O’Hara and Kotze (2010) found from their simulations that Poisson and negative binomial models yield identical parameter estimates. However, 
negative binomial and quasi-Poisson models account for overdispersed data, but by drawing on the result in Silva and Tenreyro (2006) that a Poisson 
regression with robust standard errors does not assume equidispersion, our model can cater for overdispersed data.
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but this has no implications for the out-of-sample 
counterfactual.
Having estimated Eq. 1 over the pre-COVID 
period, this fitted model is used to predict weekly 
counterfactual all-cause deaths over the out-of- 
sample period (week ending 31 January 2020 – 
week ending 28 August 2020). This provides esti-
mates of the weekly all-cause deaths if the trend 
over the estimation period continued. We then 
calculate the weekly difference between observed 
all-cause deaths and the predicted counterfactual. 
These weekly differences are the first stage weekly 
estimates of excess deaths.
Second stage modelling
In the second stage time series analysis, each esti-
mated measure of excess deaths from the first stage 
is decomposed into an estimate of the refined mea-
sure of COVID-19 excess deaths and an estimate of 
the excess mortality impact of the lockdown.
Two model specifications are estimate in 
the second stage via maximum likelihood. From 
the first, we obtain a mean weekly estimate of the 
excess mortality impact of the lockdown, and, from 
the second, we obtain individual weekly estimates 
of this impact. Both model specifications are esti-
mated using weekly time series data for Tc out-of- 
sample counterfactual (c) periods, which are 
indexed tc∈1, . . ., Tc. The first model specification 
serves as the baseline and is as follows. 
ρ̂ nð Þ ¼ γCOVIDtc q þ δLocktc q þ εtc (2) 
where ρ̂ nð Þ is the conditional mean of the estimate 
of excess deaths from the first stage, and n is 
explained by lagged COVID and Lock dummy vari-
ables. These dummies take values of 1 from the 
beginning of the COVID and lockdown mortality 
periods (and zero otherwise), and q denotes the 
assumed lag between infection and death (see sub-
section 4.2).
In this first (and also second) of the model spe-
cifications in the second stage, we explain the esti-
mate of excess deaths from the first stage using only 
variables that represent the COVID and lockdown 
mortality periods. This is for three reasons. First, 
variables used to explain deaths in the pre-COVID 
period (i.e. the first stage), such as urbanization, are 
omitted from the second stage models. This is 
because such variables are accounted for within 
the second stage as they are used to estimate the 
counterfactual deaths for the COVID period, 
which, in turn, are used to compute the estimate 
of excess deaths for the COVID period that we 
explain in the second stage.19 Second, we omit as 
a determinant in the second stage models a variable 
that measures people movement because, although 
it will impact the estimate of the refined measure of 
COVID-19 excess deaths and the estimate of the 
excess mortality impact of the lockdown, its effect 
will be captured by the COVID and Lock dummies. 
Third, the rise in working from home during the 
pandemic is consistent with a reduction in road 
traffic fatalities, but we do not include a road 
usage variable in the second stage models to take 
account of this. This is because the available daily 
road usage data that was recently introduced and 
covers only the pandemic is only for Great Britain 
and not England and Wales.20 This will though 
introduce very little (if any) bias into the estimates 
of the refined measure of COVID-19 excess deaths 
and the estimates of the excess mortality impact of 
the lockdown. This is because the COVID and Lock 
dummies are lagged by 2–5 weeks (with a prefer-
ence for 4 weeks and with some consideration of 
3 weeks) to reflect the time lag between infection 
and death (for details on this see subsection 4.2), 
while road traffic fatalities typically occur at the 
scene of the accident or very soon after, rather 
than 3 or 4 weeks after. As a result, the reduction 
in road traffic fatalities associated with the rise in 
working from home will typically be part of the 
error terms in the second stage models.21
19Relatedly, a further practical reason for this approach is that our measure of urbanization is annual which we assume applies to each week in a year (see 
subsection 4.1 for more details on this). By including urbanization in the first stage models there is variation in this variable across weeks in different years. 
Given our second stage samples only relate to part of 2020 there would be no variation in this variable in these samples. Hence the inclusion of this variable in 
the first stage models and its omission from the second stage.
20Also, this data for Great Britain is only available from 1 March 2020 and does not therefore cover all of our second stage sample as the first week of this sample 
is the week ending 31 January 2020.
21We thank an anonymous reviewer for recommending that we provide clear clarification on why in our second stage models we only include determinants 
that represent the COVID and lockdown mortality periods.
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Given excess deaths can be negative or positive, 
for the models in the second stage, we specify the 
Gaussian family of distributions and use the iden-
tity link function as this is canonical to this family. 
Therefore, the parameters on the variables that 
represent the COVID and lockdown mortality per-
iods in the fitted second stage models are marginal 
effects. From an estimate of Eq. 2, the estimates of γ 
and δ are mean weekly estimates of our refined 
measure of COVID-19 excess deaths and the excess 
mortality impact of the lockdown. This interpreta-
tion is because each estimate is relative to the 
relevant base period in the second stage sample of 
no COVID/no lockdown. Note that in Eq. 2 (and in 
the second model specification in the second stage 
that we turn to next), we omit the intercept to 
prevent it from capturing any of the COVID and 
lockdown mortality components of the second 
stage dependent variable.
Denote the set of out-of-sample counterfac-
tual time periods and the sets of COVID and 
lockdown mortality time periods Tc, J and K, 
respectively. K฀J฀Tc and the periods in J and 
K are indexed j∈1, . . ., J and k∈1, . . ., K. 
The second model specification for ρ̂ nð Þ is as 
follows. 
ρ̂ nð Þ ¼ γCOVIDtc q þ η1Lock1tc q þ . . .
þ ηKLockKtc q þ εtc (3) 
where we decompose the Lock dummy from 
Eq. 2 into K lockdown indicator variables, 
Lock1 þ . . .þ LockK, and use as regressors 
their q period lags. A lockdown indicator vari-
able takes a value of 1 in the relevant week in 
the lockdown mortality period (and zero other-
wise), and η1; . . . ; ηK are parameters to be esti-
mated and are relative to the base period of no 
lockdown. The mean of the estimates of 
η1; . . . ; ηK will approximate the estimate of 
the mean weekly excess mortality impact of 
the lockdown (δ̂) from the fitted Eq. 2. The 
estimates of η1; . . . ; ηK are therefore the weekly 
deviations about the estimate of the mean 
weekly excess mortality impact of the 
lockdown.22
IV. Data and details of the empirical model 
specifications
First stage
Using weekly time series data for the 5 years 
that precede the first confirmed cases of 
COVID-19 in York on 31 January 2020 (week 
ending 23 January 2015–24 January 2020), we 
estimate 10 first stage models. Each has 
a different all-cause deaths dependent variable: 
Total Deaths; deaths by age category (<1 year; 
1–14; 15–44; 45–64; 65–74; 75–84; and 85+, 
denoted Deaths(<1), Deaths(1–14), etc.); Male 
Deaths; and Female Deaths.23
In the first stage models, key explanatory 
variables are weekly dummies corresponding 
to calendar week numbers, where, as is stan-
dard, one is omitted. These dummies have 
a lot of explanatory power and would therefore 
appear to be good proxies for explanatory vari-
ables that were not included due to a lack of 
data (e.g. road usage).24 In the literature, these 
dummies are not cited as being key, so we 
strike a balance between retaining a small 
number of variables in the models that are 
regarded as key in the literature and where 
collectively there is the most evidence of sig-
nificance. Such variables were significant in 
a number (but not all) of the models and led 
22For our second stage sample, we could not use the same type of approach as in Eq. 3 to obtain estimates of the weekly deviations of our refined measure of 
COVID-19 excess deaths about the mean estimate from Eq. 2. This would involve estimating a model that decomposes the COVID dummy in Eq. 2 into J COVID 
indicator variables. Alternatively, to preserve degrees of freedom, one could obtain estimates of the weekly deviations of our refined measure using 
a piecewise approach. This would involve estimating multiple models where the models include different subsets of the COVID indicator variables that 
collectively represent the full set. Each model would also include a dummy that collectively accounts for the COVID indicator variables that do not enter the 
model individually. Neither approach was possible in this study due to the relatively small out-of-sample period. For a sufficiently long out-of-sample period, 
one could use at least the second of the above approaches to estimate the weekly deviations of our refined measure.
23Our deaths data are for England and Wales collectively and not for England, Wales, Scotland and Northern Ireland individually. This is because richer data is 
available for England and Wales. For our study period, weekly data on total all-cause deaths and all-cause deaths by gender and age category is only available 
for England and Wales and not for the four countries. At the time of our analysis, the available data for the four countries was a long way from being 
comparable to that for England and Wales. There has since been some improvement in the availability of data for the four countries (e.g. weekly all-cause 
deaths data by gender and age category is now available for Scotland from January 2020), but this is not comparable to that for England and Wales 
collectively / individually (e.g. weekly all-cause deaths data by gender and age category is not available for England and Wales individually).
24As we use weekly dummies, we are accounting for the weekly trends across the years in our first stage samples, and thus the differences between these 
trends for different calendar weeks.
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us to include temperature (Temp) and Urban.25 
The available temperature data for England 
and Wales are mean monthly measures. To 
construct Temp we assume that the mean 
monthly temperature applies to each week in 
the month.2627 Urban is the percentage of the 
population that live in cities with a population 
>300,000. To calculate this variable, we use 
annual mid-year estimates of the populations 
of cities and assume that the resulting annual 
Urban percentage applies to each week in 
the year.28 In terms of further explanatory 
variables such a population shares in the nine 
models for disaggregated all-cause mortalities, 
one could only rationalize including the corre-
sponding disaggregated population share. 
Given Temp and Urban represent our sample 
of determinants that are cited as key in the 
literature, we retain only those shares that are 
significant (Pop Share(<1); Pop Share(15–44); 
and Pop Share(Female)). Relevant descriptive 
statistics are provided in table 2.29
Second stage
In stage 2, each significant weekly out-of-sample 
estimate of excess deaths from stage 1 is decom-
posed into a refined estimate of COVID-19 excess 
deaths, and an estimate of the excess mortality 
impact of the lockdown. We do so by regressing 
the first stage excess deaths variable (comprising 
each out-of-sample observation minus the corre-
sponding counterfactual prediction) on variables 
that reflect the COVID-19 and lockdown mortality 
periods. The dates of the COVID-19 and lockdown 
mortality periods in the models are based on vari-
ables that assume a time lag between infection and 
death. Based on the evidence described previously, 
we focus on a 4-week lag.
In each baseline second stage model, we use two 
dummy variables to obtain mean weekly estimates 
of our refined measure of COVID-19 excess deaths 
and the excess mortality impact of the lockdown. In 
the first such model, we use the COVID4Week 
dummy, which takes a value of 1 after 4 weeks 
since the first reported cases in York through to 
the end of our study period (week ending 
6 March 2020 – week ending 28 August 2020); 
and zero for the first 5 weeks of our second stage 
sample period (week ending 31 January 2020– 
28 February 2020).30 In the same model, we include 
the Lock4Week dummy, which takes a value of 1 
from when the first blanket lockdown was active 
for 4 weeks from its start on Monday 
23 March 2020, through to 4 weeks after the end 
of the lockdown on 13 May 202031 (week ending 
24 April 2020–12 June 2020); zero otherwise. We 
examine the sensitivity of our results to the infec-
tion-mortality lag by estimating further second 
stage models using dummies based on 2, 3 or 
5 week lags (denoted COVID2Week, 
Lock2Week, etc.)
The baseline second stage models yield mean 
estimates of the refined measure of COVID-19 
excess deaths and mean estimates of the excess 
mortality impact of the lockdown. To obtain 
25This led to the number of claimants of unemployment related benefit (an indicator of economic activity) being dropped from all the models (not significant or 
counterintuitive negative sign). Also, all the age category population shares were dropped from the Total Deaths model (reasons include insignificance and 
Stata dropping due to multicollinearity).
26We also explored accounting for the possibility of a non-linear ‘U-shaped’ relationship between temperature and each of our all-cause deaths variables by 
including Temp2 in each model. The variance inflation factor for Temp2 was always way in excess of 10, which is the ‘rule of thumb’ threshold that Curto and 
Pinto (2011) use as an indicator of multicollinearity. We therefore drop Temp2 from all the models.
27Very high or very low temperatures can increase mortalities. Data on the maximum and minimum temperatures in a month in England and Wales is available 
from the Met Office. However, we omit such variables because we do not know which week in a month the maximum (minimum) applies to. This is less of 
a problem when we construct the Temp variable by assuming that the mean monthly temperature applies to each week in the month. This is because the 
temperature in each week will form part of the calculation of the mean monthly temperature. Also, as Temp comprises mean measures it will, to some extent, 
capture very high and very low temperatures.
28At the time, population data for cities and England and Wales was not available for 2020. We therefore construct the Urban variable by assuming that the 
percentage value of this variable for all the weeks in 2019 also applies to the weeks in 2020 that are part of our study period.
29Note, for the estimation period, the means of Male and Female Deaths in Table 2 do not sum exactly to the mean of Total Deaths. Over our estimation period, 
the range of the difference between Total Deaths and the sum of Male and Female Deaths is 0–25. As the ONS note, the male and female death counts may 
not sum to total deaths because of the recording of male and female deaths by age category; namely, the age category data does not include deaths where 
age is either missing or not yet fully coded.
30The error will pick up the excess deaths in these first 5 weeks. This is not an issue because it is assumed that COVID-19 will not be a cause of death in these 
weeks and it is COVID-19 deaths that we are interested in.
31We take the end of lockdown to be May 13th, as this was the date when the most strict lockdown measures were lifted. This allowed people to make 
unlimited trips outside of their home per day and to meet another person outside their household, while non-key workers were also urged to return to their 
workplace.
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(individual) weekly lockdown mortality estimates, 
we estimate further second stage regressions. This 
involves replacing each of the Lock2Week – 
Lock5Week dummy variables in the four 
baseline second stage models with their decompo-
sition into weekly indicator variables, e.g. we 
replace Lock4Week with LockApr24, 
LockMay1, . . ., LockJune12.
V. Empirical results and discussion
Estimated first stage models and predicted 
counterfactuals
Table 3 presents, for the 5-year period that pre-
cedes the pandemic, the estimates of the Poisson 
model in Eq. 1 for Total Deaths, Male Deaths 
and Female Deaths. For the same period, Table 
4 presents the estimates of the corresponding 
model for deaths in seven age categories.,3233 
For all the models in these tables and all 
the second stage models, we use robust standard 
errors to account for serial correlation (Brännäs 
and Johansson 1994).
From Tables 3 and 4, we note that a number of 
the reported coefficients on the weekly dummies are 
significant, which provides some insight into the 
substantial collective explanatory power of these 
51 weekly variables. The coefficients on Temp and 
Urban are significant in a number of models in 
these tables. The expected sign of a coefficient on 
Temp is ambiguous and, in line with this, we 
observe positive and negative coefficients. All but 
one of the significant coefficients on Temp is nega-
tive, which indicates that where the relationship is 
significant, we often find that a decrease in Temp is 
associated with a rise in mortalities. All but one of 
the significant coefficients on Urban is positive, 
where these positive estimates may be pointing to 
higher mortalities in urban areas as they are more 
densely populated. Alternatively, it is conceivable 
that a significant coefficient on Urban is negative, 
which is what we observe from the Deaths(1–14) 
Table 2. Descriptive statistics.
Variable Estimation period: week ending 
Jan 232,015–week ending Jan 242,020
Out-of-sample period: week ending Jan 312,020–week ending Aug 282,020
Mean Std. Dev. Min Max Mean Std. Dev. Min Max
Total Deaths 10,194.46 1324.59 7131 15,050 11,804.45 3765.88 8690 22,351
Deaths(<1) 51.50 8.52 22 73 46.45 7.12 28 58
Deaths(1–14) 18.53 4.48 7 32 15.32 3.52 10 22
Deaths(15–44) 285.32 33.76 146 368 293.26 38.10 219 404
Deaths(45–64) 1207.03 117.13 773 1561 1398.90 333.20 1108 2294
Deaths(65–74) 1684.73 177.60 1185 2321 1913.23 512.81 1481 3380
Deaths(75–84) 2886.62 367.06 2013 4155 3408.77 1153.05 2506 6657
Deaths(85+) 4059.17 681.22 2922 6621 4728.42 1759.90 3178 9601
Male Deaths 5027.45 599.04 3461 7117 5971.55 1978.55 4365 11,445
Female Deaths 5165.44 737.70 3670 7933 5832.81 1799.68 4280 10,906
Temp 10.19 4.42 2.60 18.60 11.72 4.14 6.10 17.20
Urban (%) 25.12 0.06 25.01 25.17 25.17 0.00 25.17 25.17
Pop Share(<1) 0.012 0.0004 0.011 0.012 0.011 0.000 0.011 0.011
Pop Share(15–44) 0.383 0.0041 0.378 0.389 0.378 0.000 0.378 0.378
Pop Share(Female) 0.506 0.0004 0.506 0.507 0.506 0.000 0.506 0.506
Note: All the data is obtained from the ONS, with the exception of the Temp variable, which was obtained from the Met Office. There are 262 observations in the 
estimation period and 31 in the out-of-sample period.
Table 3. Total, male and female first stage models (week ending 
23 January 2015 – week ending 24 January 2020).
Variable Total Deaths Male Deaths Female Deaths
Temp −0.011*** −0.009*** −0.013***
Urban 0.112* 0.255*** 1.321**
Pop Share(Female) 223.639**
Week 13 −0.162*** −0.135*** −0.189***
Week 14 −0.124** −0.095* −0.153***
Week 15 −0.103 −0.069 −0.137*
Week 16 −0.106* −0.073 −0.139**
Week 17 −0.109** −0.074* −0.144***
Week 18 −0.124** −0.085 −0.164***
Week 19 −0.161** −0.127* −0.197***
Week 20 −0.099** −0.062 −0.137***
Log-likelihood −4706.9 −2775.8 −3315.1
Notes: *, ** and *** denote statistical significance at the 5%, 1% and 0.1% 
levels, respectively. For brevity we only report parameters for selected 
weekly dummy variables in the year.
32For conciseness, the tables report the parameters for selected weekly dummy variables in the year.
33In terms of the diagnostic checks of the models in Tables 3 and 4, we use a Cook distance plot based on the corresponding OLS model specification as well as 
QQ-plots. For all the observations of the 10 dependent variables, the Cook distance is below a threshold of 1 (and for a small number of observations this 
distance marginally exceeds an alternative lower threshold of 4/262), which suggests that there are no clear outliers. The QQ-plots show that there are slight 
deviations from normality in the upper and lower tails of the error distributions from the Poisson models. These deviations are relatively minor and do not 
suggest that we need to transform any of the dependent variables. The plots are available from the corresponding author on request.
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model and may be due to better access to paediatric 
healthcare in urban areas.
In Table 5, we present for the 10 all-cause mod-
els: average weekly observed deaths over the out-of 
-sample period; average weekly predicted counter-
factual deaths over the same period; and average 
first stage excess deaths. We find that, on average, 
the following weekly first stage excess deaths are 
significantly greater than zero at the 2.5% level: 
Total Deaths; Male Deaths; Female Deaths; Deaths 
(45–64); Deaths(65–74); Deaths(75–84); and 
Deaths(85+). In each of these cases this indicates 
that the observed deaths are, on average, signifi-
cantly greater than the counterfactual deaths.
Figure 1 shows a time series of observed total 
deaths over the estimation period; and the 
observed and predicted counterfactual total deaths 
over the out-of-sample period. A visual compari-
son of the relevant portions of this figure suggests 
that our predicted counterfactual deaths do not 
look out of line with observed deaths for the same 
periods in previous years.
Estimated second stage models
Tables 6–9 present (for the out-of-sample period) 
the estimates of the second stage baseline and lock-
down indicator models (Eqs. 2 and 3) for the first 
Table 4. Age category first stage models (week ending 23 January 2015 – week ending 24 January 2020).
Variable
Deaths by Age Category
<1 1–14 15–44 45–64 65–74 75–84 85+
Temp 0.016* 0.013 0.001 0.00039 −0.004 −0.013*** −0.017***
Urban 0.029 −0.474* 0.591* 0.204*** 0.260*** 0.004 0.121
Pop Share(<1) 75.541*
Pop Share(15–44) 8.826*
Week 13 −0.059 0.061 0.219** −0.084 −0.143*** −0.159*** −0.213***
Week 14 −0.093 −0.018 0.177 −0.069 −0.112* −0.132** −0.150**
Week 15 −0.113 0.149 0.241** −0.045 −0.073 −0.115 −0.139*
Week 16 0.044 0.177** 0.262** −0.019 −0.094 −0.110* −0.151**
Week 17 −0.037 0.026 0.288*** −0.01 −0.088* −0.114** −0.162***
Week 18 −0.125 0.077 0.275** −0.067 −0.120* −0.118* −0.167***
Week 19 −0.217* 0.057 0.181 −0.11 −0.146* −0.160** −0.198***
Week 20 −0.15 0.036 0.297*** −0.013 −0.078 −0.106** −0.147***
Log-likelihood −886.0 −726.7 −1191.7 −1533.7 −1670.4 −2206.7 −3556.4
Notes: *, ** and *** denote statistical significance at the 5%, 1% and 0.1% levels, respectively. For brevity we only report parameters for selected weekly dummy 
variables in the year.
















Average SE Average SE Average SE
Total Deaths 11,804.5 3765.9 10,042.0 1014.9 1762.4 700.5
Male Deaths 5971.5 1978.6 5002.1 454.8 969.5 355.4
Female Deaths 5832.8 1799.7 4972.4 553.9 860.4 323.2
<1 46.5 7.1 49.0 3.7 −2.6 1.4
1–14 15.3 3.5 18.1 2.2 −2.7 0.7
15–44 293.3 38.1 281.3 18.1 11.9 7.6
45–64 1398.9 333.2 1212.6 86.8 186.3 61.8
65–74 1913.2 512.8 1685.5 120.9 227.7 94.6
75–84 3408.8 1153.1 2825.9 275.6 582.9 212.9
85+ 4728.4 1759.9 3963.4 525.5 765.0 329.9
Note: SE denotes standard error.
Figure 1. First stage observed and counterfactual total deaths.
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stage excess measures of Total Deaths, Male 
Deaths, Female Deaths and Deaths(85+). Tables 
A1-A3 (see Appendix) report the estimates of the 
corresponding models for the first stage excess 
measures of Deaths(45–64), Deaths(65–74) and 
Deaths(75–84). Note, the coefficients in these tables 
represent excess mortalities.
The three key findings from the results in 
Tables 6–9 are as follows. First, from our pre-
ferred baseline model (4-week infection-death 
lag) we find that: (i) COVID-19 excess deaths 
amount to 63% of the corresponding standard 
5-year average excess deaths; and (ii) in net 
terms, the lockdown increased all-cause mor-
talities (associated with an incremental 2,601 
excess mortalities per week; see coefficient on 
Lock4Week). For completeness, the aforemen-
tioned tables also show the results for our 
sensitivity analysis using lags ranging from 2 
to 5 weeks. From this we see that, as the 
assumed infection-death lag increases, there is 
a marked decline in the magnitude of the 
average weekly estimate of the excess mortality 
impact of the lockdown; accompanied by this 
Table 6. Second stage models for excess Total Deaths (first stage).
Dependent variable: excess total deaths from the first stage
Baseline models Lockdown indicator models











Lock24Apr 11,377.80*** 10,941.21*** 10,242.11***
Lock1May 7721.80*** 7285.21*** 6586.11*** 5772.12***
Lock8May 2791.80*** 2355.21*** 1656.11** 842.12
Lock15May 4091.80*** 3655.21*** 2956.11*** 2142.12**
Lock22May 2054.80*** 1618.21*** 919.11 105.12
Lock29May 1209.80*** 773.21 74.11 −739.88
Lock5June −27.79 −726.89 −1540.88
Lock12June −897.89 −1711.88*
Lock19June −2334.88**
Log-likelihood −283.87 −290.03 −294.55 −295.86 −263.22 −276.32 −288.3 −293.55
Note: *, ** and *** denote statistical significance at the 10%, 5% and 1% levels, respectively.
Table 7. Second stage models for excess Male Deaths (first stage).
Dependent variable: excess male deaths from the first stage
Baseline models Lockdown indicator models











Lock24Apr 5850.65*** 5598.74*** 5232.06***
Lock1May 3629.65*** 3377.74*** 3011.06*** 2589.06***
Lock8May 1185.65*** 933.74*** 567.06 145.06
Lock15May 1900.65*** 1648.74*** 1282.06*** 860.06
Lock22May 877.65*** 625.74** 259.06 −162.94
Lock29May 465.65** 213.74 −152.94 −574.94
Lock5June −151.26 −517.94 −939.94*
Lock12June −630.94 −1052.94*
Lock19June −1270.94**
Log-likelihood −265.63 −271.56 −275.3 −276.1 −246.49 −259.55 −269.59 −274.2
Note: *, ** and *** denote statistical significance at the 10%, 5% and 1% levels, respectively.
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impact becoming generally less significant (and 
vice-versa).34 Second, although it has been 
widely reported that COVID-19 deaths have 
been concentrated in the elderly, we find that 
such deaths have been focused in the very 
elderly (75–84 and 85+). Third, from the lock-
down indicator models,35 we can see that there 
are a small number of cases where an indicator 
parameter is negative and significant. 
Specifically, we can see from these models 
that the Lock19June parameters, and 
a number of those pertaining to Lock12June 
and Lock5June, are negative and significant 
This suggests that in net terms the lockdown 
only began to save lives 10–12 weeks after the 
policy was implemented on 23 March 2020 (or, 
alternatively, 3–5 weeks after the policy ended 
on 13 May 2020).
The implication of our results is that, at best, 
lockdown had no significant impact on net 
mortalities; and under our preferred 4-week lag 
model (and 3-week lag model, also well supported 
by the lag evidence) is associated with a significant 
net increase in mortalities. As the net impact of the 
lockdown is a function of both: (i) its efficacy 
regarding its intended effects; and (ii) the possibi-
lity of offsetting effects, in the following we con-
sider other evidence relating to these effects.
In relation to the efficacy of the lockdown, firstly, 
we note that existing studies provide mixed evi-
dence on the impact of NPIs (and lockdowns spe-
cifically) on mortalities. Whilst some report 
lockdowns reducing mortalities,36 others find no 
such impact.37 Secondly, our data findings are 
highly consistent with the first lockdown in 
England and Wales occurring after the point at 
which it could have mitigated peak COVID-19 
infections (and thus deaths).38 This is therefore 
inconsistent with a no-lockdown counterfactual 
under which COVID-19 deaths would have 
Table 8. Second stage models for excess Female Deaths (first stage).
Dependent variable: excess female deaths from the first stage
Baseline models Lockdown indicator models











Lock24Apr 5529.55*** 5345.58*** 5013.50***
Lock1May 4094.55*** 3910.58*** 3578.50*** 3186.88***
Lock8May 1603.55*** 1419.58*** 1087.50*** 695.88
Lock15May 2191.55*** 2007.58*** 1675.50*** 1283.88***
Lock22May 1179.55*** 995.58*** 663.50* 271.88
Lock29May 733.55*** 549.58** 217.5 −174.12
Lock5June 125.58 −206.5 −598.12
Lock12June −270.5 −662.12
Lock19June −1067.12**
Log-likelihood −259.3 −265.44 −270.87 −272.78 −236.62 −249.48 −264 −269.96
Note: *, ** and *** denote statistical significance at the 10%, 5% and 1% levels, respectively.
34For example, the coefficient on Lock5Week is not significant in all the relevant models in Tables 6–9 and A1-A3.
35Which in each case yield, as they should, indicator parameters that when averaged equal the coefficient on the lockdown dummy in the corresponding 
baseline model.
36Cho (2020) and Born, Dietrich, and Müller (2020) suggest that a blanket lockdown in Sweden would have reduced excess mortality. Conyon, He, and Thomsen 
(2020) find that the stringent lockdowns in Denmark and Norway, vis-à-vis Sweden, led to a reduction in mortality rates. Ciminelli and Garcia-Mandicó (2020) 
find that the shutdown of service sector activities in Italian municipalities was effective in reducing mortalities.
37Chaudhry et al. (2020) conduct a cross-country analysis of the 50 countries with the most recorded COVID-19 cases. They find that full lockdowns are not 
associated with significant reductions in critical cases or overall mortality. Gibson (2020) finds that lockdowns in New Zealand did not reduce COVID-19 
mortalities, while Li et al. (2020) find mixed results on the impact of eight NPIs on the R (where two of the NPIs are stay at home orders and restrictions on 
internal movement). For a sample of 131 countries, Li et al. find that only relaxation of school closures and bans on public events and gatherings of more than 
ten people have a significant impact on the R.
38Specifically, COVID-19 deaths by date of occurrence peaked on 8 April 2020, only 16 days after the commencement of the lockdown. Thus, even if a shorter 
lag of 3 weeks between infection and death is assumed, it would not be possible for the lockdown to have mitigated this peak.
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continued to rise.39 This finding is supported by 
Wood (2021). Thirdly, COVID-19 deaths and 
infections are highly concentrated in certain loca-
tions. Up to the start of 2021, 27% of COVID-19 
deaths in England and Wales occurred in care 
homes or hospices.40 It is intuitively doubtful 
therefore that blanket restrictions on the move-
ment of the wider population could have materially 
affected COVID-19 infections/mortalities in these 
settings (meaning that a substantial proportion of 
COVID-19 deaths may be largely invariant to blan-
ket lockdowns).41 Collectively, these points provide 
grounds to suppose that the efficacy of the first 
national lockdown in England and Wales in redu-
cing COVID-19 deaths was limited, and should not 
be presumed.
Turning to offsetting increases in other mortal-
ities, a range of evidence supports this arising in 
practice. Figure 2 contains ONS data showing non- 
COVID deaths relative to the historical 5-year 
average (i.e. non-COVID-excess deaths). This 
reveals large and rapid increases in said deaths 
that only become materially excess after the begin-
ning of lockdown (week ending 27 March 2020).
Relatedly, Griffin (2020) reports that further 
ONS data shows that up to the week ending 
1 May 2020 (where deaths were registered up to 
May 9th), only a third of excess deaths in the com-
munity (i.e. other than in hospitals) were due to 
COVID-19. In support of this, for the period 
28 December 2019–11 September 2020, the ONS 
(2020b) report that most of the 27,096 excess 
deaths in private homes in England and Wales 
did not involve COVID-19.
There is a possibility that some of the non-COVID 
excess deaths (above) may be under-diagnosed 
COVID-19 deaths. However, other research suggests 
this is unlikely. Pell et al. (2020) provide interesting 
evidence from coronial autopsies at the John Radcliffe 
Hospital (Oxford) over the first two months of the 
lockdown (i.e. from 23 March 2020). Of the 67 autop-
sies performed at the hospital pertaining to sudden 
natural deaths, the autopsy reports indicate that only 
2 deaths (3%) were undiagnosed COVID-19. 
Reduced access to healthcare systems associated 
with the lockdown was recorded as a probable con-
tributory factor to 6 deaths (9%), and a possible con-
tributory factor to a further 8 deaths (12%). These 14 
Table 9. Second stage models for excess Deaths(85+) (first stage).
Dependent variable: excess deaths (85+ years) from the first stage
Baseline models Lockdown indicator models











Lock24Apr 5426.70*** 5246.74*** 4927.89***
Lock1May 4004.70*** 3824.74*** 3505.89*** 3123.24***
Lock8May 1659.70*** 1479.74*** 1160.89*** 778.24
Lock15May 2230.70*** 2050.74*** 1731.89*** 1349.24***
Lock22May 1206.70*** 1026.74*** 707.89* 325.24
Lock29May 750.70*** 570.74*** 251.89 −130.76
Lock5June 58.74 −260.11 −642.76
Lock12June −345.11 −727.76
Lock19June −1047.76**
Log-likelihood −258.07 −264.74 −270.32 −272.3 −235.13 −249.03 −263.37 −269.4
Note: *, ** and *** denote statistical significance at the 10%, 5% and 1% levels, respectively.
39This is important, because lockdowns only ‘spread out’ infections (and thus deaths). Hence, the primary means through which they can reduce mortality is by 
‘flattening the curve’ to prevent healthcare services being overwhelmed. For that hypothetical counterfactual to be plausible, the evidence would need to 
show that infections were rising rapidly at the time of the policy intervention. More generally, given the importance of the timing of infection peaks for policy 
intervention, see Li and Linton (2021) for predictions of these peaks for the 30 countries with the largest number of cases (excluding China).
40ONS weekly data from 28 December 2019 to 1 January 2021.
41Specifically, mortality rates in care homes are more likely determined by care home policy including: visitations; staff and resident testing; and PPE equipment 
provision. Relatedly, it should be noted that many care homes unilaterally banned visits prior to the lockdown (BBC, 2021).
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cases included preventable out-of-hospital deaths, 
such as acute myocardial infarction and diabetic 
ketoacidosis, where patients contacted the health ser-
vices by telephone and were advised to self-isolate at 
home, rather than attending hospital. The authors 
also note that there was an increase in deaths from 
drug and alcohol misuse during the lockdown period.
In light of the above, as the 4 week lag baseline 
model for excess Total Deaths we favour indicates 
that the lockdown is associated with a net increase 
in excess mortalities, we posit that we have uncovered 
an important new case of the well-known Peltzman 
(1975) offsetting effect. This effect arises because peo-
ple adjust their behaviour to changes in the perceived 
level of risk. This leads to the intended effect of 
a preventative intervention to reduce risk being 
(more than) offset by the unintended consequences 
of peoples’ (over)compensating riskier behaviour. In 
this case, this conceivably arises because lockdown 
may have distorted people’s perception of COVID- 
19 risk, relative to other health conditions, potentially 
leading them: not to seek help (or not as urgently), 
causing additional mortalities. Such ‘behavioural 
change’ in peoples’ decisions on seeking healthcare 
for non-COVID-19 illnesses is consistent with what 
we observe from Figure 3, which shows monthly time 
series of A&E attendance and emergency admissions 
in England. This figure reveals a notable change in 
peoples’ choices about seeking healthcare during the 
lockdown period, as A&E attendance and emergency 
admissions collapsed despite A&E remaining open, 
with the sum of the two for April 2020 being 53% 
lower than that for the same month in 2019.
Peltzman offsetting effects have been observed in 
relation to previous safety/health interventions, 
including (i) New automobile safety regulations 
(e.g. mandatory installation of front seat belts) in 
the U.S. leading to riskier driving, meaning they had 
no overall impact on fatalities (Peltzman 1975). (ii) 
Air bags in cars in the U.S. also leading to riskier 
driving (Peterson, Hoffer, and Millner 1995). (iii) 
Higher state cigarette taxes in the U.S. leading to 
greater health risks through a rise in the consump-
tion of cigarettes with higher tar and nicotine con-
tent (Evans and Farrelly 1998). (iv) Higher state soft 
drink taxes in the U.S. leading to moderate reduc-
tions in soda consumption by children, offset by 
increases in their consumption of other high- 
calorie drinks (Fletcher, Frisvold, and Tefft 2010). 
In light of this, our finding that lockdown had off-
setting impacts should not be regarded as being in 
any way unusual.
Figure 2. ONS non-COVID excess deaths data.
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VI. Concluding remarks
The two-stage method proposed here focuses on 
addressing an omitted variables problem with 
a standard excess deaths approach; namely, 
a failure to account for policy, and other, impacts.
Our preferred baseline model indicates that the 
first national lockdown in England and Wales had 
a net mortality increasing effect. We postulate that 
this is likely a function of both low efficacy in the 
lockdown meeting its intended aim, combined with 
the presence of the Peltzman offsetting effect. 
Wider evidence supports this proposition.
Our empirical results should only be used to 
draw inferences about the excess mortality impact 
of the first blanket lockdown in England and 
Wales. Impacts of individual policy interventions 
should be evaluated case-by-case.
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Table A1: Second stage models for excess Deaths(45–64) (first 
stage)
Table A2: Second stage models for excess Deaths(65–74) 
(first stage)
Dependent variable: excess deaths (45–64 years) from the first stage
Baseline models Lockdown indicator models











Lock24Apr 941.85*** 893.42*** 832.67***
Lock1May 624.85*** 576.42*** 515.67*** 444.29***
Lock8May 149.85*** 101.42* 40.67 −30.71
Lock15May 303.85*** 255.42*** 194.67** 123.29
Lock22May 188.85*** 140.42** 79.67 8.29
Lock29May 55.85 7.42 −53.33 −124.71
Lock5June −28.58 −89.33 −160.71*
Lock12June −100.33 −171.71*
Lock19June −213.71**
Log-likelihood −210.57 −216.46 −219.67 −220.18 −192.92 −205.88 −214.17 −218.16
Note: *, ** and *** denote statistical significance at the 10%, 5% and 1% levels, respectively.
Dependent variable: excess deaths (65–74 years) from the first stage
Baseline models Lockdown indicator models











Lock24Apr 1452.65*** 1389.00*** 1293.61***
Lock1May 886.65*** 823.00*** 727.61*** 622.24***
Lock8May 263.65*** 200.00** 104.61 −0.76
Lock15May 402.65*** 339.00*** 243.61** 138.24
Lock22May 115.65** 52 −43.39 −148.76
Lock29May 73.65 10 −85.39 −190.76
Lock5June −16 −111.39 −216.76
Lock12June −131.39 −236.76
Lock19June −294.76**
Log-likelihood −225.45 −230.29 −233.59 −234.05 −207.1 −218.17 −228.39 −232.45
Note: *, ** and *** denote statistical significance at the 10%, 5% and 1% levels, respectively.
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Table A3: Second stage models for excess Deaths(75–84) 
(first stage)
Dependent variable: excess deaths (75–84 years) from the first stage
Baseline models Lockdown indicator models











Lock24Apr 3457.05*** 3314.26*** 3090.94***
Lock1May 2174.05*** 2031.26*** 1807.94*** 1559.71***
Lock8May 774.05*** 631.26*** 407.94 159.71
Lock15May 1163.05*** 1020.26*** 796.94*** 548.71*
Lock22May 523.05*** 380.26** 156.94 −91.29
Lock29May 333.05*** 190.26 −33.06 −281.29
Lock5June 1.26 −222.06 −470.29
Lock12June −318.06 −566.29*
Lock19June −734.29**
Log-likelihood −248.58 −254.39 −258.35 −259.33 −229.34 −241.95 −252.59 −257.39
Note: *, ** and *** denote statistical significance at the 10%, 5% and 1% levels, respectively.
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